tiprankstipranks
Trending News
More News >
Axon Enterprise, Inc. (AXON)
:AXON
Advertisement

Axon Enterprise (AXON) AI Stock Analysis

Compare
3,595 Followers

Top Page

AXON

Axon Enterprise

(NASDAQ:AXON)

Rating:68Neutral
Price Target:
$945.00
▲(8.98% Upside)
Axon's overall stock score is driven by strong earnings call performance and robust financial growth, despite operational inefficiencies and cash flow challenges. The high P/E ratio suggests overvaluation, and technical indicators point to potential overbought conditions. Strategic growth initiatives and international expansion are key strengths.
Positive Factors
International Growth
International revenue growth is accelerating, aided by AI breaking down cloud barriers.
Partnerships
The new partnership with Auror, the largest retail crime network in the US, represents an opportunity for AXON.
Product Innovation
Axon's constant product innovation is supporting a higher growth rate than even bullish expectations.
Negative Factors
Entry Point for Investment
The growth thesis is well understood, and there is a view to await a better entry point for investment.
Market Uncertainty
Despite the small size, the range of outcomes in International and Enterprise markets is less certain than in US State & Local.

Axon Enterprise (AXON) vs. SPDR S&P 500 ETF (SPY)

Axon Enterprise Business Overview & Revenue Model

Company DescriptionAxon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
How the Company Makes MoneyAxon Enterprise generates revenue through multiple streams. The primary revenue source is the sale of its Taser weapons, which are widely used by law enforcement agencies globally. Additionally, Axon earns revenue from its Axon Cloud segment, which includes subscriptions to its digital evidence management software and related services. The company also makes money by selling body-worn cameras and other hardware devices, often bundled with software and service subscriptions in multi-year contracts. These contracts provide a recurring revenue model that is complemented by Axon's efforts to expand its product offerings and grow its customer base through strategic partnerships and continuous innovation in public safety technology.

Axon Enterprise Key Performance Indicators (KPIs)

Any
Any
Annual Recurring Revenue
Annual Recurring Revenue
Measures the predictable revenue generated from subscriptions or contracts, highlighting the stability and growth potential of the company's income stream.
Chart InsightsAxon's Annual Recurring Revenue (ARR) has shown robust growth, surpassing $1.1 billion, a 34% increase year-over-year. This growth is fueled by strong international demand and rapid adoption of new products like TASER 10. The company projects continued momentum with a 27% revenue growth forecast for 2025. Despite potential tariff impacts and federal market uncertainties, Axon remains confident in its expansion strategy, underpinned by strong bookings and a 123% Net Revenue Retention rate.
Data provided by:Main Street Data

Axon Enterprise Earnings Call Summary

Earnings Call Date:Aug 04, 2025
(Q2-2025)
|
% Change Since: 16.41%|
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
The earnings call reflected strong performance with significant revenue and booking growth driven by new products and international expansion. The company is facing challenges with tariffs impacting future margins and some unpredictability in the Platform Solutions segment. However, the positive developments and strategic growth initiatives outweigh these concerns.
Q2-2025 Updates
Positive Updates
Strong Revenue Growth
Second quarter revenue reached $669 million, marking a 33% increase year-over-year and the 14th consecutive quarter of over 25% revenue growth.
Record-Breaking Bookings
Closed almost $150 million of bookings for the AI Era Plan in Q2, with over 30% of bookings coming from new product categories. The largest deal in company history was closed, involving a major city police department.
International Expansion
International team added a new TASER customer in Africa, becoming the largest in the region. Strong international performance with substantial deals in Q2.
Software and Services Growth
Software and services grew 39% year-over-year to $292 million, driven by the adoption of new products and high net revenue retention of 124%.
Connected Devices Growth
Connected Devices revenue increased 29% year-over-year to $376 million, driven by TASER growth of 19% and personal sensors growth of 24%.
Negative Updates
Tariff Impacts
Adjusted EBITDA margin will be impacted by tariffs in the second half of the year.
Challenges in Platform Solutions
Platform Solutions, while seeing growth, is expected to experience lumpiness due to the size and timing of deals, specifically with counter-drone solutions.
Company Guidance
During Axon's second quarter 2025 earnings call, the company reported robust growth and provided optimistic guidance for the remainder of the year. The second quarter revenue reached $669 million, marking a 33% increase year-over-year, with software and services growing by 39% to $292 million. The company also saw a 29% rise in revenue from connected devices, driven by TASER and Axon Body 4 cameras. Axon raised its revenue guidance for 2025 to a range of $2.65 billion to $2.73 billion, which represents approximately 29% annual growth at the midpoint. Additionally, the adjusted EBITDA guidance was increased to a range of $665 million to $685 million. The company highlighted the rapid adoption of new technologies such as AI, drones, and virtual reality, and noted that AI Era Plan bookings alone reached nearly $150 million in Q2. Axon emphasized its commitment to strategic investments, particularly in R&D, to sustain growth and innovation.

Axon Enterprise Financial Statement Overview

Summary
Axon Enterprise demonstrates strong revenue growth and a solid gross profit margin, reflecting effective cost management. However, profitability metrics such as net profit margin and EBIT margin have shown some decline, indicating potential operational inefficiencies. The balance sheet is stable with moderate leverage, but cash flow metrics suggest challenges in cash generation.
Income Statement
75
Positive
Axon Enterprise shows a strong revenue growth trajectory with a 7.38% increase in TTM. The gross profit margin is robust at 60.47%, indicating efficient cost management. However, the net profit margin has decreased to 13.64% from 18.10% in the previous year, and the EBIT margin is negative, reflecting potential operational challenges.
Balance Sheet
70
Positive
The company maintains a moderate debt-to-equity ratio of 0.75, suggesting a balanced approach to leverage. Return on equity is healthy at 13.43%, though it has decreased from the previous year. The equity ratio stands at 43.96%, indicating a strong equity base relative to total assets.
Cash Flow
65
Positive
Operating cash flow is positive, but the free cash flow has declined significantly by 51.33% in the TTM. The operating cash flow to net income ratio is 0.21, indicating that cash generation is lower relative to net income. The free cash flow to net income ratio is 0.64, showing some cash flow challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.39B2.08B1.56B1.19B863.38M681.00M
Gross Profit1.45B1.24B955.38M728.64M540.91M416.33M
EBITDA326.10M437.03M194.63M227.62M-149.43M-475.00K
Net Income326.31M377.03M174.23M147.14M-60.02M-1.72M
Balance Sheet
Total Assets6.22B4.47B3.41B2.85B1.69B1.38B
Cash, Cash Equivalents and Short-Term Investments2.09B986.35M1.32B974.69M443.02M561.97M
Total Debt2.05B721.67M710.66M711.11M20.44M0.00
Total Liabilities3.48B2.15B1.79B1.58B640.36M404.77M
Stockholders Equity2.73B2.33B1.61B1.27B1.05B976.25M
Cash Flow
Free Cash Flow176.49M329.53M128.99M179.25M74.22M-34.39M
Operating Cash Flow275.58M408.31M189.26M235.36M124.49M38.48M
Investing Cash Flow-1.49B-490.57M12.48M-830.97M252.56M-356.53M
Financing Cash Flow1.27B-45.44M41.31M598.10M-174.18M299.26M

Axon Enterprise Technical Analysis

Technical Analysis Sentiment
Positive
Last Price867.12
Price Trends
50DMA
765.59
Positive
100DMA
682.72
Positive
200DMA
631.76
Positive
Market Momentum
MACD
4.66
Negative
RSI
71.11
Negative
STOCH
78.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AXON, the sentiment is Positive. The current price of 867.12 is above the 20-day moving average (MA) of 747.73, above the 50-day MA of 765.59, and above the 200-day MA of 631.76, indicating a bullish trend. The MACD of 4.66 indicates Negative momentum. The RSI at 71.11 is Negative, neither overbought nor oversold. The STOCH value of 78.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AXON.

Axon Enterprise Risk Analysis

Axon Enterprise disclosed 55 risk factors in its most recent earnings report. Axon Enterprise reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Axon Enterprise Peers Comparison

Overall Rating
UnderperformOutperform
Sector (59)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$52.05B31.058.90%1.70%2.93%43.29%
76
Outperform
$84.40B21.0717.91%1.86%11.85%16.12%
71
Outperform
$84.47B21.6926.50%1.45%-0.65%77.20%
69
Neutral
$13.94B17.7011.42%0.10%1.19%-6.77%
68
Neutral
$67.51B213.4914.00%32.09%10.30%
64
Neutral
$99.98B24.1173.06%3.05%1.09%-35.50%
59
Neutral
AU$1.62B9.942.84%3.53%9.79%5.94%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AXON
Axon Enterprise
867.12
498.66
135.34%
GD
General Dynamics
313.76
28.93
10.16%
LHX
L3Harris Technologies
278.22
52.20
23.10%
LMT
Lockheed Martin
428.24
-109.20
-20.32%
NOC
Northrop Grumman
589.95
107.11
22.18%
TXT
Textron
78.22
-6.47
-7.64%

Axon Enterprise Corporate Events

Shareholder Meetings
Axon Enterprise Concludes 2025 Annual Shareholders Meeting
Neutral
Jun 2, 2025

On May 29, 2025, Axon Enterprise, Inc. held its 2025 Annual Meeting of Shareholders, where 89.8% of the company’s shares were voted. During the meeting, directors were elected for a one-year term, the compensation of named executive officers was approved in a non-binding advisory vote, and the appointment of PricewaterhouseCoopers LLP as the independent registered public accountant for fiscal year 2025 was ratified.

The most recent analyst rating on (AXON) stock is a Buy with a $645.00 price target. To see the full list of analyst forecasts on Axon Enterprise stock, see the AXON Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 06, 2025